{"disease":{"id":"interstitial-lung-disease-with-systemic-sclerosis","name":"interstitial lung disease with systemic sclerosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06732674","title":"Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":218,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT06549231","title":"Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung Disease Related to Systemic Sclerosis","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":102,"lead_sponsor_name":"University Hospital, Tours","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}